Back to Search
Start Over
The expression change of RORγt, BATF, and IL‐17 in Chinese vitiligo patients with 308 nanometers excimer laser treatment
- Source :
- Dermatologic Therapy. 31
- Publication Year :
- 2018
- Publisher :
- Hindawi Limited, 2018.
-
Abstract
- This study aims to explore the expression of RORγt, BATF, and IL-17 in Chinese vitiligo patients with 308 nm excimer laser treatment. One hundred and sixty-four vitiligo patients treated with 308 nm excimer laser were enrolled as Case group and 137 health examiners as Control group. Quantitative real-time polymerase chain reaction and immunohistochemistry were conducted to detect the expressions of RORγt, BATF, and IL-17. Expression of RORγt, BATF, IL-17A, and IL-17F were higher in Case group than Control group, with the diagnostic accuracy of 88.04, 87.38, 97.34, and 89.04%, respectively. Pearson correlation analysis showed a positive correlation in RORγt, BATF, IL-17A, and IL-17F mRNAs in vitiligo patients. Moreover, their expressions were higher in active vitiligo patients than stable ones. Besides, the expressions of RORγt, BATF, IL-17A, and IL-17F in vitiligo skin were significantly higher than those in non lesional skin and normal controls. After treatment, their expressions were significantly decreased. Active vitiligo and the high expressions of RORγt, BATF, and IL-17F were the independent risk factors for the ineffectiveness of 308 nm excimer laser treatment. The expressions of RORγt, BATF, IL-17 were significantly enhanced in vitiligo patients, which were correlated with the activity of vitiligo and 308 nm excimer laser therapeutic effects.
- Subjects :
- Adult
Male
0301 basic medicine
Adolescent
medicine.medical_treatment
Vitiligo
Diagnostic accuracy
Dermatology
Real-Time Polymerase Chain Reaction
Young Adult
030207 dermatology & venereal diseases
03 medical and health sciences
0302 clinical medicine
RAR-related orphan receptor gamma
308 nm excimer laser
BATF
medicine
Humans
Child
skin and connective tissue diseases
Aged
integumentary system
Excimer laser
business.industry
Interleukin-17
Infant
General Medicine
Middle Aged
Nuclear Receptor Subfamily 1, Group F, Member 3
medicine.disease
Immunohistochemistry
Basic-Leucine Zipper Transcription Factors
Logistic Models
030104 developmental biology
Child, Preschool
Immunology
Female
Lasers, Excimer
Interleukin 17
business
After treatment
Subjects
Details
- ISSN :
- 15298019 and 13960296
- Volume :
- 31
- Database :
- OpenAIRE
- Journal :
- Dermatologic Therapy
- Accession number :
- edsair.doi.dedup.....54aa0b95ef414fe6a7a6688f2493450c
- Full Text :
- https://doi.org/10.1111/dth.12598